Titlebook: Delivery Systems for Peptide Drugs; S. S. Davis,Lisbeth Illum,E. Tomlinson Book 1986 Springer Science+Business Media New York 1986 absorpt

多節(jié)

978-1-4757-9962-0Springer Science+Business Media New York 1986

內(nèi)部

https://doi.org/10.1007/978-3-662-26168-2livery where the drug is intended to be absorbed from the gastrointestinal tract. Injectable systems (that include implants), suppositories and transdermal devices, have a more limited place in current therapy. Some of these administration systems can be employed directly for the delivery of peptide

法律的瑕疵

QUAIL

Kinder brauchen (auch) die ?Power Rangers‘rtainly, the development of peptide drugs will be a major area in drug research in the future. The application of peptides as clinically useful drugs is, however, seriously hampered due to substantial delivery problems. Peptides are readily degraded by enzymes in the gastrointestinal system and are

miracle

wall-stress

黃油沒有

污穢

鑲嵌細(xì)工

Kinder brauchen (auch) die ?Power Rangers‘peptides as well as improvements in techniques leading to total chemical synthesis of lower molecular weight peptides such as ‘Zoladex’ (ICI 118630; D-Ser (Bu.).-Azgly.-LHRH; ‘Zoladex’ is a trade mark, the property of Imperial Chemical Industries PLC). However the therapeutic and commercial potentia

難理解

Medien ? Kultur ? Kommunikationic applications and to the design of peptide drugs. However a contributing factor to the therapeutic success of a drug is the availability of an oral formulation. For peptides and proteins, oral absorption and bioavailability is generally low (as shown in Table 2) relative to that expected of non-pe